Brief: Tiziana Life Sciences Announces Grant Received By The Brigham And Women’S Hospital To Explore The Use Of Intranasal Anti-Cd3 Mab In Amyotrophic Lateral Sclerosis
15/09/2022 12:13
Sept 15 (Reuters) - Tiziana Life Sciences Ltd TLSA.O :
* TIZIANA LIFE SCIENCES ANNOUNCES GRANT RECEIVED BY THE
BRIGHAM
AND WOMEN’S HOSPITAL TO EXPLORE THE USE OF INTRANASAL ANTI-CD3
MAB IN AMYOTROPHIC LATERAL SCLEROSIS
Source text for Eikon: ID:nGNX2q6SJn
Further company coverage: TLSA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tiziana Life Sciences
See all newsBrief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Tiziana Life Sciences rises as nasal MS drug shows promise in early study